5 Key Takeaways

• 1

  A study found that 86.2% of newly diagnosed COPD patients in the U.S. were untreated with long-acting maintenance therapy at diagnosis.

• 2

  The study analyzed data from 238,158 patients over 4 years, revealing that 63.8% remained untreated by the end of follow-up.

• 3

  Long-acting beta-agonist and inhaled corticosteroid combinations were the most common initial therapy, prescribed to 62.0% at diagnosis.

• 4

  32.9% of patients experienced at least one exacerbation during follow-up, with moderate exacerbations occurring more frequently than severe ones.

• 5

  The study highlighted the need for improved adherence to evidence-based treatment guidelines in managing COPD, especially in primary care.